Certepetide

Certepetide (CEND-1/iRGD) is a cyclic peptide that enhances tumor-specific delivery of co-administered therapeutics by binding αv-integrins and activating NRP-1. It is widely used in preclinical in vivo and in vitro research to improve drug penetration in pancreatic cancer and other solid tumor models.